Hepatitis Monthly
Volume:2 Issue: 1, Spring 2003

Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients.

Hepatitis C virus infection in hemodialysis patients in Jordan

Outcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases.--------------------------------------------------------------------------------Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations.--------------------------------------------------------------------------------Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination.--------------------------------------------------------------------------------HBcAg-specific cytokine production by CD4 T lymphocytes of children with acute and chronic hepatitis B.--------------------------------------------------------------------------------A randomized trial of consensus interferon in combination with Ribaverin as initial treatment for chronic hepatitis C--------------------------------------------------------------------------------Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan.--------------------------------------------------------------------------------Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection.